Beta Bionics, Inc.
BBNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$54,756 | -$44,099 | -$64,751 |
| Dep. & Amort. | $2,283 | $2,091 | $2,087 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $6,384 | $5,658 | $6,100 |
| Change in WC | -$12,148 | -$6,363 | -$2,790 |
| Other Non-Cash | $9,964 | $10,268 | -$854 |
| Operating Cash Flow | -$48,273 | -$32,445 | -$60,208 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$3,395 | -$402 | -$772 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$72,131 | $0 | $0 |
| Inv. Sales/Matur. | $72,000 | $0 | $0 |
| Other Inv. Act. | $50 | -$69,291 | $3 |
| Investing Cash Flow | -$3,476 | -$69,693 | -$769 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $55,615 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $101,029 | $56,782 |
| Financing Cash Flow | $55,615 | $101,029 | $56,782 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $3,866 | -$1,109 | -$4,195 |
| Supplemental Information | – | – | – |
| Beg. Cash | $26,666 | $27,775 | $31,970 |
| End Cash | $30,532 | $26,666 | $27,775 |
| Free Cash Flow | -$51,668 | -$32,847 | -$60,980 |